Kevin Richard Back

Title: Kevin Richard Back: Innovator in Pharmaceutical Formulations

Introduction

Kevin Richard Back is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for intravenous administration. With a total of 2 patents, his work is recognized for its potential impact on patient care.

Latest Patents

Kevin's latest patents focus on formulations of a PI3K/mTOR-inhibitor for intravenous administration. The first patent describes a pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. This formulation is particularly suitable for intravenous or parenteral administration to a patient. The second patent also relates to a similar formulation, emphasizing the importance of clear solutions for effective delivery to patients.

Career Highlights

Kevin Richard Back is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on innovative solutions that enhance drug delivery methods and improve patient outcomes.

Collaborations

Throughout his career, Kevin has collaborated with talented individuals such as Michael Cram and Aidan James Harper. These collaborations have fostered an environment of innovation and creativity, contributing to the advancement of pharmaceutical formulations.

Conclusion

Kevin Richard Back is a distinguished inventor whose work in pharmaceutical formulations has the potential to significantly improve intravenous drug administration. His contributions to the field are invaluable, and his ongoing efforts continue to shape the future of patient care.